You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: June 21, 2024

Investigational Drug Information for SHR3162


✉ Email this page to a colleague

« Back to Dashboard


What is the drug development status for SHR3162?

SHR3162 is an investigational drug.

There have been 20 clinical trials for SHR3162. The most recent clinical trial was a Phase 1 trial, which was initiated on August 19th 2020.

The most common disease conditions in clinical trials are Prostatic Neoplasms, Breast Neoplasms, and Carcinoma, Ovarian Epithelial. The leading clinical trial sponsors are Jiangsu HengRui Medicine Co., Ltd., Atridia Pty Ltd., and Fudan University.

There are two US patents protecting this investigational drug and twenty-one international patents.

Recent Clinical Trials for SHR3162
TitleSponsorPhase
SNF Platform Study of HR+/ HER2-advanced Breast CancerFudan UniversityPhase 2
A Trial of SHR3162 Combined With Apatinib Mesylate Tablets or SHR3162 Monotherapy in Patients With Metastatic Castration Resistant Prostate CancerJiangsu HengRui Medicine Co., Ltd.Phase 2
A Phase III Study of Fuzuloparib Combined With Abiraterone Acetate and Prednisone (AA-P) Versus Placebo Combined With AA-P as First-Line Treatment in Patients With Metastatic Castration-Resistant Prostate Cancer (mCRPC)Jiangsu HengRui Medicine Co., Ltd.Phase 3

See all SHR3162 clinical trials

Clinical Trial Summary for SHR3162

Top disease conditions for SHR3162
Top clinical trial sponsors for SHR3162

See all SHR3162 clinical trials

US Patents for SHR3162

Drugname Patent Number Patent Title Patent Assignee Estimated Expiration
SHR3162 ⤷  Sign Up Phthalazinone ketone derivative, preparation method thereof, and pharmaceutical use thereof Jiangsu Hansoh Pharmaceutical Co., Ltd. (Lianyungang, Jiangsu, CN) ⤷  Sign Up
SHR3162 ⤷  Sign Up Methods of using phthalazinone ketone derivatives Jiangsu Hansoh Pharmaceutical Co., Ltd. (Lianyungang, Jiangsu, CN) ⤷  Sign Up
>Drugname >Patent Number >Patent Title >Patent Assignee >Estimated Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.